Sentences with phrase «women with cancer at»

Not exact matches

But there are also the moments of tragedy — someone we love dies of cancer, there is an appalling airplane crash, we hear about a devastating earthquake or a tidal wave, famine strikes some part of the world — when any man or woman who is at all sensitive will admit that this is not «a nice world» but rather is filled with tragedy, sadness, and pain.

Women with PCOS are at increased risk for endometrial cancer.

However, with the exception of women who consumed a high intake of soy during adolescence, the majority of epidemiological studies (studies carried out in defined population groups) have not found that women with higher soy intakes are at lower risk of breast cancer.

«As a family company, we're passionately committed through Touching Lives to empower women with access to support and services at every step of their cancer journey,» said J. Lohr Vineyards & Wines Co-Owner and Trade and Brand Advocate Cynthia Lohr.

We estimated the variability of differences in the population prevalence of maternal cancers, type 2 diabetes mellitus, hypertension, MI, and premature mortality when women breastfed at current compared with optimal rates and the proportion of current disease burden that this change would reflect.

I should look closer at the cancer data, but given the rates of breastfeeding over the last few decades, especially of breastfeeding past 1 year, I would guess that most of the cancer data comes from women with several shorter lactations.

«For women with a family history of breast cancer, this suggests an extra benefit [of breastfeeding] is, it may reduce the risk of breast cancer,» says Alison Stuebe, MD, an assistant professor of obstetrics and gynecology at the University of North Carolina at Chapel Hill, the lead author of the study.

The new board member is a pediatric psychologist who works with children who have cancer or severe blood diseases at Women and Children's Hospital of Buffalo.

Commenting on research, to be published in the July issue of The Oncologist, looking at discrimination in treatment of older women with breast cancer.

With new tests to identify women who are at heightened risk of breast cancer, new drugs aimed at preventing allergies, and the discovery of new genes that are key to the progression of conditions like Alzheimer's - to give just three examples - we are at the dawn of a whole new era:

Commenting on research, to be published in the July issue of The Oncologist, looking at discrimination in treatment of older women with breast cancer, Jane Hatfield, Director of Policy and Research at Breast Cancer Care,cancer, Jane Hatfield, Director of Policy and Research at Breast Cancer Care,Cancer Care, said:

Starting at age 21, women should be screened regularly for cervical cancer with a Pap test and possibly in combination with an HPV (human papillomavirus).

In April, the U.S. Centers for Disease Control and Prevention reported for 2013 - 2014 that among adults ages 18 to 59, 25 percent of men and 20 percent of women had genital infections with HPV types that put them at risk of developing cancer.

«Here at Valley, we are proud to offer this option for our patients and are excited about its potential for vastly improving patient care for women with breast cancer.»

To determine whether this long held belief is true, investigators from John Wayne Cancer Institute utilized their institution's melanoma database to analyze data on 2,025 women age 18 to 50 diagnosed with stage I to IV melanoma who were treated at their institution between 1971 and 2016.

In fact, African - American women had higher cancer rates at nearly all ages compared with white women, and the disparity was more pronounced at older ages, likely attributable to African - American women reporting a higher prevalence of hysterectomy than white women.

«Estimating from various studies that looked at increasing BMI and endometrial cancer risk, a woman with a Body Mass Index (BMI) of 40 would have approximately eight times greater risk of endometrial cancer than someone with a BMI of 25,» said first author Kristy Ward, MD, the senior gynecologic oncology fellow in the Department of Reproductive Medicine at UC San Diego School of Medicine.

«Our results provide evidence for clinicians to consider HRT as compared with CRT as a preferred radiation treatment in men with intermediate - risk prostate cancer and at low risk of other complications,» stated Trevor Royce, MD, MPH, radiation oncologist at Brigham and Women's Hospital and first author of the study.

We identified patients with mutations that predict phenomenal outcomes in the disease; this is a group of women with endometrial cancer who won't need the financial, physical or emotional toll of chemotherapy at all — they're patients who are probably cured by surgery alone.

Among the changes in the American Cancer Society's updated breast cancer screening guideline is that women with an average risk of breast cancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue ofCancer Society's updated breast cancer screening guideline is that women with an average risk of breast cancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue ofcancer screening guideline is that women with an average risk of breast cancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue ofcancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue of JAMA.

Researchers at the Georgia Institute of Technology collected blood from 44 women diagnosed with ovarian cancer at various stages, along with that from 50 healthy controls.

Women with inflammatory bowel disease (IBD) may be at increased risk of cervical dysplasia and cancer, according to a new study1 published in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

In January, Jeffrey Engelman, a thoracic oncologist at Massachusetts General Hospital in Boston, and his colleagues detailed the case of a 52 - year - old woman with metastatic lung cancer in The New England Journal of Medicine.

Women with the variant were at much higher risk for cancer, had more recurrences, were often hit with multiple cancers and were more likely to die from aggressive forms of these diseases.

«But we also saw a significant reduction — 11 percent — in the risk of dying from cancer,» added Fuchs, who is also affiliated with the Channing Division of Network Medicine at Brigham and Women's.

Researchers at the University of Texas Medical Branch at Galveston are the first to recommend that young women treated with radiation for cervical cancer should begin colorectal cancer screening earlier than traditionally recommended.

Li says he and colleagues at the Fred Hutchinson Cancer Research Center and the University of Washington found the correlation between migraines and breast cancer during a survey of 2,000 post-menopausal women with breast cancer and 1,500 post-menopausal women with no history of breast cCancer Research Center and the University of Washington found the correlation between migraines and breast cancer during a survey of 2,000 post-menopausal women with breast cancer and 1,500 post-menopausal women with no history of breast ccancer during a survey of 2,000 post-menopausal women with breast cancer and 1,500 post-menopausal women with no history of breast ccancer and 1,500 post-menopausal women with no history of breast cancercancer.

«What we've discovered will help clinicians to better treat women with ovarian cancer,» says Dr. Ben Tsang, senior scientist at the Ottawa Hospital Research Institute and professor at the University of Ottawa.

In contrast, an older woman with multiple other diseases or life - limiting conditions, and without any risk factors for breast cancer, will only be at risk of over-diagnosis and overtreatment and may not benefit from screening.»

People with the altered form of the gene have at least a 70 per cent chance of developing colon cancer at some time in their lives, and women with the gene also have at least a 50 per cent chance of developing cancer of the uterus.

«Mayo Clinic is now developing new studies that will focus on the role of CDK 4/6 inhibitors and their potential to inhibit cancer metastasis in women with triple - negative breast cancer who are at highest risk for cancer metastasis.»

Women with a family history of two or more immediate family members (mother, sister, daughter) with breast or ovarian cancer or with a positive genetic test for mutations in the BRCA1 or BRCA2 genes may be advised to consider having both breasts removed, because they are at high risk of a new cancer developing in the other breast.

«These findings give us reason to rethink how we manage prostate cancer in men with known heart disease,» said Anthony D'Amico, MD, lead author of the research paper and chief of genitourinary radiation oncology at Brigham and Women's Hospital..

But the most striking statistic in the study results came from the 19 percent of women who had bilateral mastectomy with reconstruction, a procedure that offers little to no benefit for women at low risk for developing a second cancer.

«These are women with advanced metastatic cancer whose disease was kept in check without the use of toxic and life - disrupting chemotherapy,» says Dr. Massimo Cristofanilli, M.D., Director of the Breast Care Center at Thomas Jefferson University and senior author of the study.

«The compelling results seen in this global study provide unequivocal evidence supporting the clinical utility of Oncotype DX to risk - stratify patients with early stage breast cancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medcancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of MedCancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medicine.

Women with severe disability, across levels of chronic conditions, had the lowest rate of breast cancer screening at 61 per cent.

«Our findings highlight the potential value for a randomized controlled trial of aspirin as an agent in early detection of breast cancer, particularly for women with naturally dense tissues who may be at an increased risk for certain cancers,» said Despina Kontos, PhD, assistant professor of Radiology, and co-author on the study.

Among postmenopausal women with normal body mass index (BMI), those with higher body fat levels had an increased risk for invasive breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27 - 30.

In our day and age, when growing numbers of women of reproductive age are diagnosed with thyroid cancer and when fertility problems are rampant, these findings should serve as an additional consideration for physicians contemplating radioactive iodine for their patients,» said senior author Karen Tordjman, MD, associate professor of medicine at the Sackler Faculty of Medicine of Tel Aviv University.

They took account of psychiatric history and they also looked more closely at the difference in suicidal behaviour in women who had been diagnosed with cervical cancer or a precursor to cervical cancer (the equivalent of cervical intraepithelial neoplasia grade 3, or CIN3).

Co-author Dr. Susan Cu - Uvin, professor of public health and of obstetrics and gynecology at Brown, said women with HIV are especially susceptible to cervical cancer from HPV because their weakened immune systems are less able to clear the virus.

The researchers also found that compared with white women, Asian / Pacific Islander women had higher odds of presenting with HER2 - overexpressing breast cancer, a difference that was also observed at every level of socioeconomic status.

Preliminary results of a study of patients with prostate cancer show that MR tractography may be a reliable quantitative imaging biomarker to assess prostate cancer treatment response to androgen deprivation and radiation therapy, according to a team of researchers at Brigham and Women's Hospital and Massachusetts General Hospital in Boston.

«Our discovery is particularly notable as we enter the era of personalized medicine,» said senior author Steffi Oesterreich, Ph.D., professor in Pitt's Department of Pharmacology and Chemical Biology and at UPCI, a partner with UPMC CancerCenter, and director of education at the Women's Cancer Research Center.

Nearly 20 percent of women with ovarian cancer do not undergo surgery, despite it being a standard part of treatment recommendations, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

The findings, which suggest women may live four times longer with surgical treatment, were especially striking among older patients; researchers found that nearly half of women over 75 with stage III / IV cancer do not have surgery and roughly 25 percent receive no treatment at all.

Up to half of women with advanced - stage ovarian cancer might be cured, compared to the current 20 per cent survival rate, argues Dr. Steven Narod, senior scientist at Women's College Research Institute, who calls for a new standard of treatment for women with late - stage ovarian cawomen with advanced - stage ovarian cancer might be cured, compared to the current 20 per cent survival rate, argues Dr. Steven Narod, senior scientist at Women's College Research Institute, who calls for a new standard of treatment for women with late - stage ovarian caWomen's College Research Institute, who calls for a new standard of treatment for women with late - stage ovarian cawomen with late - stage ovarian cancer.

Study findings were consistent with previous research suggesting that elderly women are at high - risk for inadequate surgical treatment of cancer.

If a woman with a strong family history of breast and ovarian cancers tests negative for the BRCA1 / 2 genes, that does not mean her relatives are not at risk, says Daly — her siblings could still carry the gene, or there could be additional genes present that predispose them to cancer that clinicians don't yet know how to test for.